Applied O O O O
Epidemiology O O O O
Generating O O O O
Data O O O O
for O O O O
the O O O O
Prevention O O O O
of O O O O
Infectious O O O O
Diseases O O O O
Our O O O O
Applied O O O O
Epidemiology O O O O
program O O O O
partners O O O O
with O O O O
local O O O O
researchers O O O O
in O O O O
high-risk O O O O
communities O O O O
to O O O O
gather O O O O
and O O O O
analyze O O O O
data O O O O
on O O O O
infectious O O O O
disease O O O O
spread O O O O
and O O O O
the O O O O
impact O O O O
of O O O O
new O O O O
vaccines. O O O O
Positioned O O O O
at O O O O
the O O O O
intersection O O O O
of O O O O
research O O O O
and O O O O
policy, O O O O
the O O O O
team O O O O
strengthens O O O O
the O O O O
evidence O O O O
base O O O O
through O O O O
an O O O O
expansive O O O O
research O O O O
portfolio O O O O
and O O O O
subsequently, O O O O
translates O O O O
that O O O O
evidence O O O O
into O O O O
action O O O O
for O O O O
prevention. O O O O
Generating Reason 5 O O
Evidence Reason 5 O O
for Reason 5 O O
Action Reason 5 O O
Our Reason 5 O O
Applied Reason 5 O O
Epidemiology Reason 5 O O
Program Reason 5 O O
generates Reason 5 O O
evidence Reason 5 O O
for Reason 5 O O
vaccine Reason 5 O O
policy Reason 5 O O
makers, Reason 5 O O
including Reason 5 O O
conducting Reason 5 O O
clinical Reason 5 O O
surveillance Reason 5 O O
to Reason 5 O O
measure Reason 5 O O
burden Reason 5 O O
of Reason 5 O O
disease Reason 5 O O
and Reason 5 O O
studying Reason 5 O O
vaccine Reason 5 O O
safety Reason 5 O O
and Reason 5 O O
immunogenicity, Reason 5 O O
effectiveness, Reason 5 O O
and Reason 5 O O
impact. Reason 5 O O
We Reason 5 O O
are Reason 5 O O
committed Reason 5 O O
to Reason 5 O O
generating Reason 5 O O
actionable Reason 5 O O
results, Reason 5 O O
and Reason 5 O O
use Reason 5 O O
our Reason 5 O O
global Reason 5 O O
advocacy Reason 5 O O
experience Reason 5 O O
to Reason 5 O O
translate Reason 5 O O
data Reason 5 O O
into Reason 5 O O
tools Reason 5 O O
for Reason 5 O O
the Reason 5 O O
prevention Reason 5 O O
of Reason 5 O O
infectious Reason 5 O O
diseases. Reason 5 O O
"The O O O O
COVID-19 O O O O
pandemic O O O O
created O O O O
pressure O O O O
for O O O O
an O O O O
effective O O O O
vaccine, O O O O
which O O O O
led O O O O
to O O O O
large O O O O
doses O O O O
being O O O O
tested O O O O
to O O O O
ensure O O O O
efficacy; O O O O
however, O O O O
if O O O O
Sabin O O O O
finds O O O O
that O O O O
lower O O O O
doses O O O O
can O O O O
be O O O O
as O O O O
effective O O O O
as O O O O
full O O O O
doses, O O O O
more O O O O
vaccines O O O O
may O O O O
be O O O O
available O O O O
for O O O O
more O O O O
people O O O O
if O O O O
they O O O O
are O O O O
needed." O O O O
Denise O O O O
Garrett O O O O
Vice O O O O
President, O O O O
Applied O O O O
Epidemiology O O O O
[Dose-Optimizing O O O O
COVID-19 O O O O
Vaccine O O O O
Clinical O O O O
Trial](https://www.sabin.org/resources/sabin-vaccine-institute-receives-up-to-6-3-million-from-cepi-for-dose-optimizing-covid-19-vaccine-clinical-trial/) O O O O
Sabin O O O O
was O O O O
awarded O O O O
up O O O O
to O O O O
$6.3 O O O O
million O O O O
from O O O O
the O O O O
Coalition O O O O
for O O O O
Epidemic O O O O
Preparedness O O O O
Innovations O O O O
(CEPI) O O O O
for O O O O
a O O O O
clinical O O O O
trial O O O O
to O O O O
evaluate O O O O
the O O O O
immunogenicity O O O O
and O O O O
safety O O O O
of O O O O
lower, O O O O
fractional O O O O
doses O O O O
of O O O O
registered O O O O
COVID-19 O O O O
vaccines O O O O
used O O O O
as O O O O
a O O O O
booster O O O O
dose. O O O O
[](https://www.sabin.org/resources/sabin-vaccine-institute-receives-up-to-6-3-million-from-cepi-for-dose-optimizing-covid-19-vaccine-clinical-trial/) O O O O
[Disease Reason 4 O O
Burden Reason 4 O O
Surveillance Reason 4 O O
Studies](https://www.sabin.org/disease-burden-surveillance-studies/) Reason 4 O O
Learn Reason 4 O O
more Reason 4 O O
about Reason 4 O O
our Reason 4 O O
partnerships Reason 4 O O
in Reason 4 O O
Bangladesh, Reason 4 O O
Nepal Reason 4 O O
and Reason 4 O O
Pakistan Reason 4 O O
track Reason 4 O O
typhoid Reason 4 O O
and Reason 4 O O
paratyphoid Reason 4 O O
and Reason 4 O O
measure Reason 4 O O
the Reason 4 O O
impact Reason 4 O O
of Reason 4 O O
vaccine Reason 4 O O
roll Reason 4 O O
out. Reason 4 O O
Also, Reason 4 O O
read Reason 4 O O
about Reason 4 O O
our Reason 4 O O
study Reason 4 O O
to Reason 4 O O
validate Reason 4 O O
accessible Reason 4 O O
tests Reason 4 O O
for Reason 4 O O
typhoid Reason 4 O O
so Reason 4 O O
that Reason 4 O O
communities Reason 4 O O
can Reason 4 O O
better Reason 4 O O
assess Reason 4 O O
disease Reason 4 O O
spread Reason 4 O O
â€” Reason 4 O O
and Reason 4 O O
the Reason 4 O O
need Reason 4 O O
for Reason 4 O O
vaccines. Reason 4 O O
[](https://www.sabin.org/disease-burden-surveillance-studies/) Reason 4 O O
[A O O O O
Community O O O O
Dedicated O O O O
to O O O O
Eliminating O O O O
Typhoid](https://www.sabin.org/communities/coalition-against-typhoid/) O O O O
With O O O O
the O O O O
Coalition O O O O
against O O O O
Typhoid, O O O O
Sabin O O O O
brings O O O O
together O O O O
researchers O O O O
and O O O O
scientists O O O O
determine O O O O
to O O O O
eradicate O O O O
this O O O O
disease O O O O
through O O O O
improved O O O O
sanitation O O O O
and O O O O
the O O O O
introduction O O O O
of O O O O
vaccines. O O O O
[](https://www.sabin.org/communities/coalition-against-typhoid/) O O O O
[International O O O O
Conference O O O O
on O O O O
Typhoid O O O O
& O O O O
Other O O O O
Invasive O O O O
Salmonelloses](https://www.coalitionagainsttyphoid.org/typhoid-conference/past-conferences/12th-conference-resources/) O O O O
Every O O O O
two O O O O
years, O O O O
we O O O O
hold O O O O
a O O O O
conference O O O O
that O O O O
brings O O O O
together O O O O
researchers, O O O O
policymakers O O O O
and O O O O
advocates O O O O
to O O O O
advance O O O O
a O O O O
clear O O O O
agenda O O O O
for O O O O
prevention O O O O
and O O O O
control O O O O
of O O O O
typhoid O O O O
and O O O O
related O O O O
diseases. O O O O
[](https://www.coalitionagainsttyphoid.org/typhoid-conference/past-conferences/12th-conference-resources/) O O O O
Publications O O O O
and O O O O
Journal O O O O
Articles O O O O
[End O O O O
COVID-19 O O O O
in O O O O
Low- O O O O
and O O O O
Middle-income O O O O
Countries](https://www.science.org/doi/10.1126/science.abo4089) O O O O
We O O O O
make O O O O
vaccines O O O O
more O O O O
accessible, O O O O
enable O O O O
innovation O O O O
and O O O O
expand O O O O
immunization O O O O
across O O O O
the O O O O
globe O O O O
